电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CCR2 Protein-VLP (AA 1-360)

This VLP CCR2 protein is expressed in HEK-293 Cells.
产品编号 ABIN7448153
发货至: 中国

Quick Overview for CCR2 Protein-VLP (AA 1-360) (ABIN7448153)

抗原

See all CCR2 蛋白
CCR2 (Chemokine (C-C Motif) Receptor 2 (CCR2))

蛋白类型

VLP

生物活性

Active

宿主

  • 11
  • 3

资源

  • 7
  • 2
  • 2
  • 2
  • 1
HEK-293 Cells

应用范围

ELISA, Immunogen (Imm), Surface Plasmon Resonance (SPR), Functional Studies (Func)

纯度

> 95 % as determined by HPLC
  • 产品特性

    AA 1-360

    原理

    Human CCR2b Protein-VLP

    序列

    Met1-Leu360

    产品特性

    Recombinant Human CCR2b Protein-VLP is expressed from HEK293.It contains Met1-Leu360.

    过滤

    0.22 μm filtered

    内毒素水平

    Less than 1EU per μg by the LAL method.

    Biological Activity Comment

    Immobilized Human CCR2b VLP at 5μg/ml (100μl/Well) on the plate. Dose response curve for Anti-CCR2b Antibody, hFc Tag with the EC50 of 12.0ng/ml determined by ELISA.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!
    Product
    表达系统
    Conjugate
    Origin
    价格从
    表达系统 HEK-293 Cells
    Conjugate His tag
    Origin Human
    价格从 136,947.45 ¥
    表达系统 Cell-free protein synthesis (CFPS)
    Conjugate Strep Tag
    Origin Human
    价格从 172,528.32 ¥

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 应用备注

    • Antibody Discovery: Immunization, Screening, Functional Characterization
    • Affinity determination: ELISA, SPR
    • In vivo pharmacokinetic analysis
    • CMC method development
    • CAR-T Positive Rate Detection
    • Blood sample determination: ELISA

    说明

    Virus-like particles (VLPs) are formed from the outer capsid protein of a virus and are tiny nanoparticles formed by the automatic assembly of one or more capsid proteins. VLPs do not contain viral infectious genomes, so they are relatively safe during production operations. The SAMS™ protein engineering platform has been used to express a series of biotinylated, non-biotinylated, and fluorescently-labeled VLP-displayed antigens. They are suitable for SPR, ELISA, CAR-T positive rate detection, and other experimental scenarios.

    Virus-Like Particles (VLPs) are highly immunogenic, meaning that they can elicit a strong immune response in the host. VLPs are recognized by the immune system and are taken up by antigen-presenting cells (APCs) such as dendritic cells. Once taken up by APCs, VLPs are processed and presented to T cells, which can trigger the activation of B cells to produce antibodies against the displayed antigen. Because VLPs resemble the structure and composition of native viruses, they are highly effective at inducing both humoral and cellular immune responses.

    Generally, VLPs range in size from approximately 20 to 200 nanometers (nm). Compared to a cell-based immunization approach, their smaller size can optimize the immune response to target the specific antigen displayed on the surface of the engineered VLPs.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Supplied as 0.22μm filtered solution in PBS, 300 mM L-Arginine ( pH 7.4). Notice: If you need it for immunization, Do Not use any adjuvant.

    储存条件

    -80 °C

    储存方法

    Valid for 12 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

    有效期

    12 months
  • 抗原

    CCR2 (Chemokine (C-C Motif) Receptor 2 (CCR2))

    别名

    CCR2b

    背景

    The chemokine (C-C motif) receptor 2B (CCR2B) is one of the two isoforms of the receptor for monocyte chemoattractant protein-1 (CCL2), the major chemoattractant for monocytes, involved in an array of chronic inflammatory diseases. The actin-binding protein filamin A (FLNa) as a protein that associates with the carboxyl-terminal tail of CCR2B. FLNa emerges as an important protein for controlling the internalization and spatial localization of the CCR2B receptor in different dynamic membrane structures.

    分子量

    42.9kDa.

    UniProt

    P41597-2

    途径

    cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Chat with us!